comparemela.com

Latest Breaking News On - European heart journal digital health - Page 4 : comparemela.com

Digital cardiovascular care company tenacio announces publication of benefit analysis in European Heart Journal Digital Health

tenacio announces the publication of Universal Clinician Device for improving risk prediction and management of patients with atrial fibrillation.

Can Your Bedtime Determine Your Heart Health?

Post-Vax Myocarditis Scare; Left Main Bifurcation PCI; Arrhythmogenic 2016 Election?

New York Times) In response, leaders of the American Heart Association and American Stroke Association assured the public that vaccination s benefits still outweigh the risks. Excess pericardial fat was linked to heart failure, especially among women. ( Journal of the American College of Cardiology) Did the 2016 U.S. presidential election trigger cardiac arrhythmias? ( Journal of the American Heart Association) Young Latinos who are overly anxious about having a heart attack also tend to have mental health problems, University of Houston researchers said. Stroke) The TVT Registry provided reassuring 1-year data on low-risk patients with bicuspid aortic stenosis undergoing transcatheter aortic valve replacement with Sapien 3 and Sapien 3 Ultra devices.

Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health

Acarix AB: Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health Acarix AB (publ) today announced the publication of the Prognostic study, a study with long term follow up on patients from the Dan-NICAD 1 publication. The long term Prognostic data from the Dan-NICAD 1 trial was first presented at the ESC Congress in September 2019 by Simon Winther, MD, PhD from Aarhus University Hospital, Denmark. The Dan-NICAD 1 trial was initiated in September 2014 to assess non-invasive methods in patients referred to coronary CTA due to symptoms suggestive of obstructive CAD. Clinically relevant prognostic data were assessed with a median follow-up time of 3 years to evaluate the correlation between CAD-score and prognosis in patients treated by current standard of care.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.